| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024589881 |
| P356 | DOI | 10.1007/S10620-010-1400-5 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s10620-010-1400-5 |
| P698 | PubMed publication ID | 20848203 |
| P2093 | author name string | Takashi Takeuchi | |
| Kazunori Imada | |||
| Yutaka Shimizu | |||
| Akiko Kawashima | |||
| Kiyoshi Mizuguchi | |||
| Tsuyoshi Harada | |||
| Satoshi Kajikawa | |||
| P2860 | cites work | Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity | Q73246068 |
| Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease | Q78654225 | ||
| Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 | Q83161496 | ||
| Polyunsaturated fatty acids stimulate hepatic UCP-2 expression via a PPARalpha-mediated pathway | Q28191448 | ||
| Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression | Q28367828 | ||
| Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells | Q31906559 | ||
| Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription | Q34369949 | ||
| Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis | Q34578231 | ||
| Pathogenesis and management issues for non-alcoholic fatty liver disease | Q36179902 | ||
| Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. | Q36365999 | ||
| n-3 fatty acids and the metabolic syndrome | Q36536076 | ||
| Suppression of hepatic fat accumulation by highly purified eicosapentaenoic acid prevents the progression of d-galactosamine-induced hepatitis in mice fed with a high-fat/high-sucrose diet | Q38354453 | ||
| Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat/high-sucrose diet-fed mice | Q38355498 | ||
| 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells | Q42454202 | ||
| In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation. | Q42994685 | ||
| Protective effects of eicosapentaenoic acid on genotoxicity and oxidative stress of cyclophosphamide in mice | Q43201528 | ||
| Activity of the leukocyte NADPH oxidase in whole neutrophils and cell-free neutrophil preparations stimulated with long-chain polyunsaturated fatty acids | Q43568775 | ||
| Fish oil feeding alters liver gene expressions to defend against PPARalpha activation and ROS production | Q43862660 | ||
| In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases | Q44036833 | ||
| Polyunsaturated fatty acids as antioxidants. | Q44692726 | ||
| Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis | Q44810635 | ||
| Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease | Q46869764 | ||
| Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. | Q51500156 | ||
| P433 | issue | 4 | |
| P921 | main subject | reactive oxygen species | Q424361 |
| P304 | page(s) | 1065-1074 | |
| P577 | publication date | 2010-09-17 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Eicosapentaenoic acid attenuates progression of hepatic fibrosis with inhibition of reactive oxygen species production in rats fed methionine- and choline-deficient diet | |
| P478 | volume | 56 |
| Q40707212 | Amelioration of hepatic inflammation in a mouse model of NASH using a dithiocarbamate derivative |
| Q42289779 | Chemoprotective effect of omega-3 fatty acids on thioacetamide induced hepatic fibrosis in male rats |
| Q89699887 | Combined effect of n-3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: a double-blind placebo-controlled clinical trial |
| Q37017917 | Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis. |
| Q36524312 | Efficacy of alogliptin in preventing non-alcoholic fatty liver disease progression in patients with type 2 diabetes |
| Q35588868 | Eicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient mice |
| Q27023122 | Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stress |
| Q41102448 | Long-Term Administration of Eicosapentaenoic Acid Improves Post-Myocardial Infarction Cardiac Remodeling in Mice by Regulating Macrophage Polarization |
| Q61805470 | Omega-3 and -6 fatty acid plasma levels are not associated with liver cirrhosis-associated systemic inflammation |
| Q26825517 | Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease |
| Q34760318 | Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice |
| Q92468986 | Protective effects and mechanisms of omega-3 polyunsaturated fatty acid on intestinal injury and macrophage polarization in peritoneal dialysis rats |
| Q52771993 | Reversal of myofibroblastic activation by polyunsaturated fatty acids in valvular interstitial cells from aortic valves. Role of RhoA/G-actin/MRTF signalling. |
| Q34479248 | Rodent models for metabolic syndrome research |
| Q39796475 | Therapeutic effect of flax-based diets on fatty liver in aged laying hens |
| Q50718528 | Transcriptomic and epigenetic changes in early liver steatosis associated to obesity: effect of dietary methyl donor supplementation. |
| Q38782562 | Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview |
| Q37111117 | ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation. |
Search more.